Bruker (BRKR) Long-Term Investments (2023 - 2026)

Bruker (BRKR) has reported Long-Term Investments for 3 consecutive years, with $37.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Long-Term Investments changed N/A year-over-year to $37.6 million; the trailing twelve-month figure through Jun 2026 stood at $37.6 million (changed N/A YoY), and the FY2024 full-year result was $113.6 million, up 40.25% from the prior year.
• Long-Term Investments retreated to $37.6 million in Q2 2026 per BRKR's latest filing, from $113.6 million in the prior quarter.
• Across five years, Long-Term Investments topped out at $113.6 million in Q4 2024 and bottomed at $37.6 million in Q2 2026.
• Historically, Long-Term Investments has averaged $77.4 million across 3 years, with a median of $81.0 million in 2023.
• The widest YoY moves for Long-Term Investments: up 40.25% in 2024, down 40.25% in 2024.
• Over 3 years, Long-Term Investments stood at $81.0 million in 2023, then surged by 40.25% to $113.6 million in 2024, then plunged by 66.9% to $37.6 million in 2026.
• According to Business Quant data, Long-Term Investments over the past three periods registered $37.6 million, $113.6 million, and $81.0 million for Q2 2026, Q4 2024, and Q4 2023 respectively.